Cost-benefit analysis of hepatic resection, radiofrequency ablation and liver transplantation in small hepatocellular carcinoma

References

• Merchant N1, Cs D, Cunningham SC, et al. Early hepatocellular carcinoma: transplantation versus resection: the case for liver resection. Int J Hepatol. 2011;14:2085.
   Google Scholar
• Sotiropoulos GC, Drühe N, Sgourakis G, et al. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?. Dig Dis Sci. 2009;54(10):2264–2273.
   PubMed Web of Science ®Google Scholar
• Lee KK1, Dg K, Is M, et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010;101(1):47–53.
   PubMed Web of Science ®Google Scholar
• Wall WJ, Marotta PJ. Surgery and transplantation for hepatocellular cancer. Liver Transpl. 2000;6(Suppl 6):S16–22.
   PubMed Web of Science ®Google Scholar
• European Association for study of liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48(5):599–641. European Organization for research and treatment of cancer.
   PubMed Web of Science ®Google Scholar
• Abu-Hilal M. Surgical resection versus percutanous radiofrequency of ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointestinal Surg. 2008;12(5):1521–1526.
   PubMed Web of Science ®Google Scholar
• Giuliante. Liver resection for hepatocellular carcinoma ≤3cm: results of an Itatian mulricenter study on 588 patients. J Am Collsurg. 2012;215(2):244–254.
   PubMed Web of Science ®Google Scholar
• Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–328.
   PubMed Web of Science ®Google Scholar
• Xu G, Qi FZ, Zhang JH, et al. Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. 2012;10(1):163.
   Google Scholar
• Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;240(1):102–107.
   PubMed Web of Science ®Google Scholar
• Stein K, Rosenberg W, Wong J, et al. Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut. 2002;50(2):253–258.
   PubMed Web of Science ®Google Scholar
• Wright M, Grieve R, Roberts J, et al. HeaOLTh benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. HeaOLTh Technol Assess. 2006;10(21):1–113.
   Web of Science ®Google Scholar
• Siegel DM, Ma J, Zou Z, et al. Cancer statistics 2014. CA J Clin. 2014;64(1):9–29.
   PubMed Web of Science ®Google Scholar
• Parkin D, Bray MF, Ferlay J, et al. Estimating the world cancer burden: globocan 2000. Int J Cancer. 2001;94(2):153–156.
   PubMed Web of Science ®Google Scholar
• Kow AWC. Transplantaton versus live resection in patients with hepatocellular carcinoma. Transl Gastroenterol Hepatol. 2019 May 17; 4:33.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Vitale A, Ejaz A, et al. The reaOLTive net heaOLTh benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg. 2015 Jun;39(6):1474–1484.
   PubMed Web of Science ®Google Scholar
• Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer. Cancer Control. 2018 Jan; 25(1):1073274817744621.
   Web of Science ®Google Scholar
• Perini MV, Starkey G, Fink MA, et al. From minimal to maximal surgery inthe treatment of hepatocarcinoma: areview. World J Hepatol. 2015 Jan 27;7(1):93–100.
   PubMed Web of Science ®Google Scholar
• Liu B, Wei M, Liu F, et al. Radiofrequency ablation plus nucleotide analogous for hepatitis B-related hepatocellular carcinoma: a cost-effectiveness analysis. Am J Transl Res. 2018 Aug 15;10(8):2685–2695.
   PubMed Web of Science ®Google Scholar
• Medical Administration of the National Health Commission, People’s Republic of China. Standardization for diagnosis and treatment of primary hepatic carcinom(2019 edition). Zhongguo Shiyong Waike Zazhi. 2020;40(02):121–138.
   Google Scholar
• Chen SL, Jin HL, Dai ZH, et al. Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma. Cancer Med. 2019;8(4):1530–1539.
   PubMed Web of Science ®Google Scholar
• Azzam AZ. Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol. 2015;7(10):1347–1354.
   PubMed Web of Science ®Google Scholar
• Kumaran V. Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(Suppl 3):S97–103.
   PubMedGoogle Scholar
• Akoad ME, Pomfret EA. Hepatic resection and liver transplantation for hepatocellular carcinoma. Clin Liver Dis. 2015;19(2):381–399.
   PubMed Web of Science ®Google Scholar
• Naugler WE. Survival and cost‐effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma. Liver Transpl. 2010;16:1186–1194.
   PubMed Web of Science ®Google Scholar
• Gupta N, Verma R, Dhiman RK, et al. Cost-effectiveness analysis and decision modelling: a tutourial for clinicians. J Clin Exp Hepatol. 2020 Mar-Apr;10(2):177–184.
   PubMed Web of Science ®Google Scholar
• Lin S. Randomised controlled trial comparing percautaneous radiofrequecy thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injetion to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151–1156.
   PubMed Web of Science ®Google Scholar
• Livraghi. Sustained complete response and complications rates after radiofrequecy ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatologyp. 2008;47:82–89.
   PubMed Web of Science ®Google Scholar